Showing results (1-10 of 116) with videos related to
Sort By:
Pageof 12
Cell Cycle (Georgetown, Tex.)|December 21, 2012
MicroRNA: a third dimension in autophagyHaiyan Zhai, Andrew Fesler, Jingfang JuOncotargets and Therapy|September 5, 2014
miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancerAndrew Fesler, Haiyan Zhai, Jingfang JuMolecular Diagnosis & Therapy|February 26, 2014
Circulating microRNA testing for the early diagnosis and follow-up of colorectal cancer patientsAndrew Fesler, Jingting Jiang, Haiyan Zhai, et al.Oncotarget|May 19, 2015
Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagyHaiyan Zhai, Andrew Fesler, Yufeng Ba, et al.Clinical Colorectal Cancer|September 10, 2013
Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancerHaiyan Zhai, Andrew Fesler, Kristina Schee, et al.Journal of Pancreatology|March 6, 2020
Development of microRNA-based therapy for pancreatic cancerAndrew Fesler, Jingfang JuFrontiers in Genetics|November 25, 2011
Implications of microRNAs in colorectal cancer development, diagnosis, prognosis, and therapeuticsHaiyan Zhai, Jingfang JuOncotarget|September 9, 2017
Expression analysis of microRNA as prognostic biomarkers in colorectal cancerJie Yang, Dongling Ma, Andrew Fesler, et al.Oncotarget|February 9, 2018
Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1Andrew Fesler, Hua Liu, Jingfang JuCancer Translational Medicine|October 18, 2016
Implications of Circadian Rhythm Regulation by microRNAs in Colorectal CancerSong Wu, Andrew Fesler, Jingfang JuPageof 12